Company: HCWB
Filing Date: 2025-04-01
Form Type: 8-K
Source: 0000950170-25-048619
Chunk: 5

Company: HCW Biologics Inc.
Filing Date: 2025-04-01
Form: 8-K
Item: Item 7.01
Chunk 5
---
Item 7.01 Regulation FD Disclosure.

On April 1, 2025, the Company issued a press release announcing the Reverse Stock Split. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Exhibit 99.1 is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.